ArticleFrontiers in pharmacology2022

Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy.

Tian TianPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.